News

With a record number of innovative drugs queued for FDA approval, managed healthcare executives have an eye toward innovative new products that tackle difficult conditions.

With a country-wide focus on reducing the cost of prescription drugs, managed healthcare executives make their forecasts concerning the future of list prices.

How social media is opening new study opportunities.

New study shows that the public thinks about SDOH differently than academics.

The Trump Administration is calling for better price transparency to help control healthcare costs-but is publishing list prices enough?

One study suggests that, after accounting for other factors, MSSPs do not have any impact on outcomes or costs.

Study shows Medicaid expansion could result in more favorable heart health.

How the right benefit design can help increase patient engagement and adherence to key maintenance therapies.

A new study analyzed the effects of telemedicine vs. face-to-face interventions for insomnia.

The service is designed to help CVS Caremark PBM clients more easily contract, implement, and manage their choice of available and emerging third-party health and wellness benefit solutions.

As healthcare becomes more patient-centric, can healthcare technology keep up?

What the move could mean for patient outcomes.

A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.

Being a CEO can be a fulfilling-yet demanding-role. Here are 12 stress-busters that promote self-care.

Enrollment impacts an MAO’s revenue and profitability and is a key driver to becoming successful. Here are ways to better understand enrollment potential for new organizations.

New study finds that SDOH can affect cardiac health.

With Anthem’s announcement that it will acquire Beacon Health Options, analysts say it makes for insurers to get more into mental healthcare.

How healthcare executives are thinking about the future of healthcare technologies.

The rare disease community struggles to balance care with costs.

While aggressive early intervention may be useful for diabetes patients, that intervention must be sustained.

How healthcare executives can develop a deep understanding of the patient populations they serve.

These are the important policies to watch out for in 2019.

The first step in helping consumers navigate the cost of care is to provide them with a basic understanding of what healthcare services actually cost.

CMS introduced indication-based formularies as a voluntary tool for plans to implement in 2020.

A new survey has surprising results about the one issue that keeps hospital and healthcare executives awake at night.

A new report found that OCM practices have a harder time achieving benchmarks than predicted.

Why Medicare Advantage isn’t as popular for first-year Medicare beneficiaries.

Are accelerated approvals having as much impact as the FDA hopes?